Barcelona

• A Phase 1 Study for ZW251 in Participants with Solid Tumors. Recruiting
  2025-523088-39-00 1 2026-01-28 Advanced Solid Tumors
• Phase IIB Study of PHENOGENE-1A (Cromolyn) as an Adjuvant Therapy in Mild to Moderate ALS Recruiting
  2025-520688-42-00 4 2026-01-27 Amyotrophic Lateral Sclerosis (ALS)
• A Phase 2/3 clinical trial with zanzalintinib versus everolimus Recruiting
  2025-521043-20-00 10 2026-01-27 Neuroendocrine tumors
• A clinical study to test if an investigational treatment called BNT314 when used in combination with another investigational treatment pumit … Recruiting
  2025-521768-36-00 9 2026-01-27 Metastatic colorectal cancer
• Phase 1/2 Study of PYX-201 in Combination with Pembrolizumab in Advanced Solid Tumors Recruiting
  2025-521828-30-00 9 2026-01-27 Advanced Solid Tumors
• Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer with Disease Progression on or Af … Recruiting
  2025-522400-24-00 10 2026-01-27 Metastatic urothelial cancer
• A Phase 1-2 Master Protocol to Study Intravenous ATTR-01 in Adult Participants with Select Epithelial Solid Tumours Under Multiple Sub-proto … Recruiting
  2024-516722-59-00 7 2026-01-23 Select Epithelial Solid Tumours
• A trial to learn how safe AZD5335 is and if a drug called itraconazole changes how AZD5335 moves through the body over time in adults with o … Recruiting
  2025-522731-34-00 3 2026-01-23 Ovarian cancer Primary peritoneal cancer Fallopian tube cancer
• A Study in Adults with Parkinson's Disease and a Lack of Interest or Motivation to Test How Different Doses of IRL757 Given for Multiple Day … Recruiting
  2025-523612-37-00 3 2026-01-23 Parkinson's Disease and Apathy
• Randomized Phase 3 Trial of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carc … Recruiting
  2024-515023-11-00 5 2026-01-22 Metastatic Clear Cell Renal Cell Carcinoma
• Trial of Trastuzumab Deruxtecan in Combination with Pembrolizumab Versus Pembrolizumab with Platinum-based Chemotherapy in First-line HER2 o … Recruiting
  2024-515658-26-00 5 2026-01-21 Unresectable or Metastatic HER2 overexpressing and PD-L1 TPS <50% Non-
• A Study of Amivantamab in Addition to Standard of Care Agents Compared with Standard of Care in Participants With Recurrent/Metastatic Head … Recruiting
  2025-521917-24-00 5 2026-01-21 Treatment-Naïve Recurrent/Metastatic Head and Neck Squamous Cell Carci
• A study to learn about how well BAY 3401016 works in adults with Alport syndrome Recruiting
  2024-516471-33-00 4 2026-01-19 Alport Syndrome
• A Study to test ALE.P03 in Adult Patients with Selected Advanced or Metastatic CLDN1+ Solid Tumors Recruiting
  2025-521441-24-00 7 2026-01-19 Advanced or Metastatic Solid Tumors
• A Study to Evaluate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of Xdivane versus Opdivo® in Patients with Resected Melanoma Recruiting
  2025-522307-14-00 2 2026-01-19 Melanoma
• Effect of Semaglutide on embryo quality in overweight and obese patients undergoing In Vitro Fertilization. A Randomized Controlled Trial Recruiting
  2025-522525-34-00 6 2026-01-19 Infertility
• ​​Vorasidenib for the treatment of IDH-mutant astrocytoma after standard chemoradiotherapy Recruiting
  2024-519404-27-00 5 2026-01-16 ​​IDH-mutant grade 2 or 3 astrocytoma​
• A study to find a suitable dose of ASP5834 in adults with solid tumors Recruiting
  2025-522082-29-00 1 2026-01-16 Locally advanced (unresectable) or metastatic solid tumor malignancies
• A Study to Compare the Efficacy and Safety of Prasinezumab with a placebo in Participants with Early-Stage Parkinson’s Disease Recruiting
  2025-522683-32-00 5 2026-01-15 Early-Stage Parkinson’s Disease (PD)
• STATIN-PRE trial Recruiting
  2024-519853-12-00 5 2026-01-14 intrauterine growth restriction
• A Clinical study of MK-4716 in people with certain solid tumors (MK-4716-001) Recruiting
  2025-522495-84-00 7 2026-01-14 Cancer – Solid Tumors : 1L NSCLC and all other advanced or metastatic
• A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee ( ATTAIN-OA PAIN ) Recruiting
  2025-522631-34-00 5 2026-01-14 Osteoarthritis
• A Phase 2a double blind, randomized, parallel arm, placebo-controlled trial to investigate the effects of two dose levels of CIT-013 on dise … Recruiting
  2025-521684-12-00 4 2026-01-13 Hidradenitis Suppurativa
• A trial to learn how safe AZD4512 is and how it works in the bodies of people with B-cell acute lymphoblastic leukemia (B-ALL) Recruiting
  2025-522372-93-00 7 2026-01-13 B-cell acute lymphoblastic leukemia (B-ALL)

Showing 745–768 of 3,391 trials